PubMed Health⌕ Search

PubMed · 12966668

[Optimizing resources in nuclear cardiology].

Abstract

Myocardial perfusion SPECT imaging (MPI) provides substantial diagnostic and prognostic information in patients with known or suspected coronary artery disease (CAD). Furthermore, it has been demonstrated that the application of MPI results is a cost-effective modification of patient management. Several studies have demonstrated that a chest pain center (CPC) using MPI significantly reduce the number of patients hospitalized from the emergency department for further evaluation of chest pain, and restricted hospitalization to more appropriate patients. However, time-consuming and costs of MPI studies might represent a significant issue for patients and nuclear laboratory logistics. We addressed the question whether in patients evaluated for CAD stress with only MPI might reduce costs and time without loosing the efficacy for detecting CAD. We included a consecutive series of 122 patients. All patients underwent stress-only Tc99m sestamibi MPI. The study population was divided into two groups: group I consisted of 26 patients with stress-only abnormal MPI and group 2 consisted of 96 patients with stress-only normal MPI. All group I patients underwent angiography and showed a significant lesion in at least one vessel in 22 patients. Mean follow-up of group II patients was 12.65 +/- 2.83 months and the overall cardiac event rate was 0.2%. Stress-only MPI was completed in a shorter period of time than reststress MPI (57 +/- 5.95 vs 180 +/- 2 minutes, p < 0.000.1). In addition, stress-only MPI studies saved 40% of costs. We concluded that in patients with low to medium pretest probability for CAD, stress-only MPI results in a safety strategy that improves cost-efficiency and decreases demand on nuclear laboratory time.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Enrique Vallejo Venegas. [Optimizing resources in nuclear cardiology].. https://pubmed.ncbi.nlm.nih.gov/12966668/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Investigating the mechanisms linking vitamin D to coronary artery disease: A mediating proteomics Mendelian randomisation study.

Coronary artery disease (CAD) is a leading cause of mortality and morbidity globally, with its elevated rates of disability and death posing a significant public health concern. Vitamin D is a crucial bioactive compound involved in numerous physiological processes and has garnered considerable interest due to its potential health benefits. The association between vitamin D and CAD has been a prominent focus of scholarly investigation. However, there remains considerable debate regarding whether vitamin D confers protective effects against CAD, and the underlying mechanisms by which vitamin D influences CAD remain inadequately understood. Mendelian randomization analysis was performed using large-scale genome-wide association study data to examine the causal relationship between serum 25-hydroxyvitamin D (25(OH)D) levels and CAD. Plasma proteomics data were subsequently employed for mediation analysis, followed by enrichment analysis to identify intermediary metabolic or signaling pathways through which serum 25(OH)D may mediate the onset and progression of CAD. The Mendelian randomization analysis indicated that higher serum 25(OH)D levels were associated with a reduced risk of CAD (odds ratio [95% confidence interval]: 0.799 [0.643-0.993], P&#x2005;=&#x2005;.043). No evidence of pleiotropy (P&#x2005;=&#x2005;.949) or heterogeneity (P&#x2005;=&#x2005;.630) was observed in the results. The protein-mediated analysis identified 19 plasma proteins, including Serine/threonine-protein kinase TBK1, membrane associating domain domain-containing protein 2, and interleukin-17D, as key mediators through which reduced vitamin D levels contribute to the development of CAD. The mediation effects ranged from 4.85 to 34.49%. Following the identification of these 19 mediating proteins, 59 intermediary pathways were further pinpointed through which serum vitamin D influences CAD risk. Increased levels of 25(OH)D may reduce the risk of CAD. Further, plasma proteomics-mediated analyses have uncovered potential mechanisms through which 25(OH)D influences the development of CAD, offering a detailed framework for understanding the relationship between vitamin D deficiency and CAD progression. This provides novel evidence to support the recommendation of appropriate vitamin D supplementation as part of lifestyle guidance for CAD patients.

Coronary Artery Disease↗

From here to eternity: a unified kinetic model for the pathophysiology of atherosclerotic events.

Two operative pathophysiological models underlie the clinical management of ischemic heart disease: a physical model founded on the magnitude of vascular stenosis and a biochemical model founded on the inflammatory processes within the atherosclerotic plaque. Despite their complementary natures, these 2 models are implicitly competitive--the stenotic model supporting the primacy of aggressive interventional procedures and the inflammatory model supporting the primacy of conservative medical management. We unified these alternative perspectives through a kinetic model that characterizes the pathophysiology of cardiovascular events as a network of exponential transitions between the inflammatory and stenotic states. According to this model, the prevalence of the normative (nonstenotic and noninflammatory) state falls exponentially, while the prevalences of the inflammatory and stenotic states rise to a peak and then fall off exponentially. According to this model, event rate increases as a complex function of both myocardial ischemia and vascular inflammation. Although the model has yet to be prospectively validated, it provides a theoretical foundation for predicting the degree to which atherosclerotic events are due to inflammation versus stenosis and the degree to which they can thereby be prevented by treatment strategies directed at plaque stabilization or relief of ischemia.

Coronary Artery Disease↗